ArticleFrontiers in oncology2026
Malignant breast adenomyoepithelioma with diagnostic discordance: a case report and literature review.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Malignant adenomyoepithelioma (MAME) of the breast is a rare biphasic neoplasm with potential for local recurrence and distant metastasis. Preoperative diagnosis is often difficult because core needle biopsy (CNB) may undersample the biphasic and malignant features of the tumor. We report an 84-year-old woman, among the oldest described patients, who presented with a newly palpable left breast nodule. Breast ultrasonography demonstrated an indistinct hypoechoic subareolar lesion, and mammography showed a corresponding focal asymmetry without suspicious calcifications. CNB suggested invasive carcinoma of no special type with a triple-negative immunophenotype. The patient underwent breast-conserving surgery (BCS) with sentinel lymph node biopsy (SLNB) and an intraoperative radiotherapy (IORT) boost. Final pathology confirmed grade 3 malignant MAME measuring 16 mm, with perineural invasion and a Ki-67 proliferation index of 20%. Immunohistochemistry confirmed a biphasic epithelial and myoepithelial nature. Surgical margins were negative, and sentinel lymph nodes were uninvolved. The patient subsequently received adjuvant capecitabine chemotherapy and supplemental whole-breast irradiation (WBI), with only grade 1 hand-foot syndrome, and showed no evidence of disease at 15 months of short-term follow-up. A pooled literature review showed substantial discordance between CNB and final pathology, supporting complete excision with comprehensive immunohistochemical evaluation. The principal contribution of this report is to highlight histologic-subtype discordance, in contrast to the malignancy-level discordance more commonly described, as a complementary diagnostic challenge in MAME. Across reported cases, negative-margin resection remained the cornerstone of management, lymph node involvement was uncommon, and late recurrence or distant metastasis could occur.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.